TORONTO, ON / ACCESSWIRE /?November 4, 2021 /?Novamind?Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"),?a leading mental health company specialized in psychedelic medicine, today announced
TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased
Novamind Ventures Inc : Novamind Uplists to OTCQB Venture Market finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The Deal Would Create the Largest Enterprise in the Cannabis Industry By Revenue
Shares of Canadian Licensed-Producers (LPs) Aphria (TSX:APHA) (NYSE:APHA) (FRA: 10E) and Tilray (NASDAQ:TLRY) (FRA: 2HQ) traded higher following the news about the two companies merging. Benzinga caught up with Aphria CEO and chairman Irwin D. Simon, who will maintain those two positions in the new company, and Tilray CEO Brendan Kennedy, who will serve in the new corporation’s board of directors alongside one other person picked by Tilray, and seven others (including Simon) from Aphria.
Source: Shutterstock
Revive’s Clinical Safety Team Has Actively Monitored the Ongoing Interim Data of Patients and Found There Have Been No Safety Concerns and No Severe Adverse Events During the Interim Analysis Enrollment Period